Israel Active

Electronic Medical Records transformed Israel’s health system and convinced the USA to implement them. Sensing technology is the next big advance. Jerusalem’s symposium “Connected Health and Vulnerable Populations” showed how Israel is a prototype for global better health.

ALS sufferers live longer in Israel.  In global terms, between 5 and 10 percent of ALS sufferers survive more than 10 years after being diagnosed. But in Israel, 20 percent of ALS patients survive longer.  The high survival rate is thought to be due to family support systems, the Israeli health care system and early diagnosis.  (link expired) (link should work)  

Israel’s BrainStorm, together with Canadian company Octane Biotech, has built a bioreactor for commercial production of the stem cells used as a basis for the company's treatment for ALCS. The ability to multiply stem cells is critical for the treatment's success.

Virologist Dr. Leslie Lobel from Ben Gurion University is developing a vaccine to defeat the Ebola virus by studying the immune systems of the disease’s survivors. He has spent 12 years studying the disease in Uganda.

Normally, foreign investors acquire Israeli biotechs that develop cancer treatments. But here, Israel’s Redhill Biopharma has bought pancreatic cancer treatment RP101 from Germany’s RESprotect GmbH. RP101 has passed Phase II trials and has vital orphan status.

Israel’s MMATech Ltd develops components for total hip implants, made of a revolutionary Polyimide material, MP1 developed originally for the aerospace industry. They are self-lubricating, durable, and have a long lifespan. MMATech is raising funds for FDA approval.

In the last decade, mortality rates have plummeted, especially for cancer, strokes, respiratory disease and diabetes. Life is more healthy here than in the USA and Europe.

Israeli start-up Oxitone literally keeps a “watch” on blood-oxygen levels affecting the heart. Two optical lasers are built into an oximeter that sits on the wrist. GE Healthcare chose Oxitone from 400 companies and is the only foreign company to join GE’s entrepreneur program.

Israeli biotech BiondVax has announced that its M-001 vaccine has been validated against all H7 virus strains, thus protecting against all avian (bird) flu variations.

Nazareth based Alpha Omega has won the American-Israeli Chamber of Commerce’s Eagle Star Award for its medical device to treat neurological disorders like Parkinson’s disease. The sophisticated microelectrode technology allows doctors to stimulate and record the brain’s natural electrical impulses.